# Study to Assess Drug-Drug Interaction Between Itraconazole or Gemfibrozil and JNJ-56021927

> **NCT02230033** · PHASE1 · COMPLETED · sponsor: **Aragon Pharmaceuticals, Inc.** · enrollment: 45 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-56021927
- **DRUG:** Itraconazole
- **DRUG:** Gemfibrozil

## Key facts

- **NCT ID:** NCT02230033
- **Lead sponsor:** Aragon Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2016-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02230033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02230033, "Study to Assess Drug-Drug Interaction Between Itraconazole or Gemfibrozil and JNJ-56021927". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02230033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*